Long-Term (1-Year) Safety and Efficacy of a Single 6-mL Injection of Hylan G-F 20 in Indian Patients with Symptomatic Knee Osteoarthritis.

Pal, Sarvajeet; Thuppal, Sreedhar; Reddy, K J; Avasthi, Sachin; Aggarwal, Anish; Bansal, Himanshu; Mohanasundaram, Senthilnathan; Bailleul, Francois

Pal, Sarvajeet; Thuppal, Sreedhar; Reddy, K J; Avasthi, Sachin; Aggarwal, Anish; Bansal, Himanshu; Mohanasundaram, Senthilnathan; Bailleul, Francois.

Afiliação

Pal S; Advance Rheumatology Clinic, Andhra Pradesh, India.
Thuppal S; Kamineni Hospitals, Andhra Pradesh, India.
Reddy KJ; Apollo Hospitals, Andhra Pradesh, India.
Avasthi S; Department of Orthopaedics, GSVM Medical College and Associated Hospital, Uttar Pradesh, India.
Aggarwal A; Brij Medical Centre, Uttar Pradesh, India.
Bansal H; Genzyme India Pvt. Ltd., Haryana, India.
Mohanasundaram S; Sanofi-Synthelabo (India) Ltd., Mumbai, India.
Bailleul F; Genzyme Biosurgery (Formerly), Saint Germain en Laye Cedex, France.

Open Rheumatol J ; 8: 54-68, 2014.

Article em En | MEDLINE | ID: mdl-25328555

Palavras-chave

Hyaluronan; Western Ontario and McMaster Universities Osteoarthritis Index.; hylan G-F 20; osteoarthritis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Risk_factors_studies Idioma: En Revista: Open Rheumatol J Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Índia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google